These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Combined hormone therapy in hyperplasia of the endometrium]. Bespoiasnaia VV; Tumasian KP; Voronovskaia IV Lik Sprava; 2000 Sep; (6):49-52. PubMed ID: 11452920 [TBL] [Abstract][Full Text] [Related]
5. [Hormone therapy and the risk of cancer in the climacteric]. Kuhl H; Taubert HD Gynakologe; 1986 Dec; 19(4):259-65. PubMed ID: 3817599 [No Abstract] [Full Text] [Related]
6. [Effect of progestins on the ultrastructure of endometrial cells in pretumorous changes and cancer (an organ-culture study)]. Beliaeva LA; Bukhvalov IB; Zheleznov BI; Raĭkhlin NT Arkh Patol; 1982; 44(4):18-25. PubMed ID: 7082195 [TBL] [Abstract][Full Text] [Related]
7. Apoptosis may be an early event of progestin therapy for endometrial hyperplasia. Amezcua CA; Lu JJ; Felix JC; Stanczyk FZ; Zheng W Gynecol Oncol; 2000 Nov; 79(2):169-76. PubMed ID: 11063639 [TBL] [Abstract][Full Text] [Related]
8. [Treatment of hyperplastic processes in the endometrium of women of child-bearing age using different types of synthetic progestins]. Manuilova IA; Sotnikova EI Akush Ginekol (Mosk); 1978 Mar; (3):39-42. PubMed ID: 347966 [TBL] [Abstract][Full Text] [Related]
9. [Fibrinolytic activity of the endometrium during treatment with synthetic progestins]. Rotkina IE; Tsibizova SA Akush Ginekol (Mosk); 1977 Dec; (12):36-9. PubMed ID: 605978 [No Abstract] [Full Text] [Related]
10. Endometrial hyperplasia. Risks, recognition and the search for a safe hormone replacement regimen. de Lignieres B J Reprod Med; 1999 Feb; 44(2 Suppl):191-6. PubMed ID: 11392031 [TBL] [Abstract][Full Text] [Related]
12. Endometrial factors under treatment with oestrogen and oestrogen/progestogen combinations. Aylward M; Maddock J; Parker A; Protheroe DA; Ward A Postgrad Med J; 1978; 54 Suppl 2():74-81. PubMed ID: 740584 [TBL] [Abstract][Full Text] [Related]
14. Levonorgestrel-releasing intrauterine system (Mirena) as a therapy for endometrial hyperplasia and carcinoma. Bahamondes L; Ribeiro-Huguet P; de Andrade KC; Leon-Martins O; Petta CA Acta Obstet Gynecol Scand; 2003 Jun; 82(6):580-2. PubMed ID: 12780432 [No Abstract] [Full Text] [Related]
15. [Restoration of the menstrual and generative functions in genital endometriosis after treatment with various types of synthetic progestins]. Nagovitsina AI; Teleliutina FK; Kravchuk TA Akush Ginekol (Mosk); 1980 Oct; (10):47-9. PubMed ID: 7446857 [TBL] [Abstract][Full Text] [Related]
17. [New preparations for treatment of climacterial disorders]. Nesheim BI Tidsskr Nor Laegeforen; 1979 May; 99(15):792-3. PubMed ID: 462446 [TBL] [Abstract][Full Text] [Related]
18. Surface ultrastructural response of the human uterine lining epithelium to hormonal environment. A scanning electron microscopic study. Ferenczy A Acta Cytol; 1977; 21(4):566-72. PubMed ID: 269610 [No Abstract] [Full Text] [Related]
19. [The use of the Norcolut preparation in gynecologic; practice]. Bozhinova S Akush Ginekol (Sofiia); 1996; 35(3):50-1. PubMed ID: 9045566 [TBL] [Abstract][Full Text] [Related]
20. Norethindrone--a review of therapeutic applications. Taitel HF; Kafrissen ME Int J Fertil Menopausal Stud; 1995; 40(4):207-23. PubMed ID: 8520623 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]